Found: 6
Select item for more details and to access through your institution.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1641, doi. 10.1007/s10637-021-01152-z
- By:
- Publication type:
- Article
Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11380-6
- By:
- Publication type:
- Article
Enfortumab Vedotin in urothelial cancer.
- Published in:
- Therapeutic Advances in Urology, 2020, v. 12, p. 1, doi. 10.1177/1756287220980192
- By:
- Publication type:
- Article
Fabrication and Characterization of PDMS Waveguides for Flexible Optrodes.
- Published in:
- Advanced Healthcare Materials, 2024, v. 13, n. 16, p. 1, doi. 10.1002/adhm.202304513
- By:
- Publication type:
- Article
Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 1, p. 21, doi. 10.1007/s40487-020-00135-z
- By:
- Publication type:
- Article
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article